Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 1; doi:10.1093/annonc/mdj116
[Extract] [FREE Full Text] [PDF] [Request Permissions]

editorial:

D. J. Kerr

Concordia res parvae crescent
Ann Oncol 17: 3-4; doi:10.1093/annonc/mdj122
[Extract] [FREE Full Text] [PDF] [Request Permissions]

reviews:

L. M. Woods, B. Rachet, and M. P. Coleman

Origins of socio-economic inequalities in cancer survival: a review
Annals of Oncology Advance Access published on September 2, 2005
Ann Oncol 17: 5-19; doi:10.1093/annonc/mdj007
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference
Annals of Oncology Advance Access published on November 28, 2005
Ann Oncol 17: 20-28; doi:10.1093/annonc/mdj078
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

original articles:

gastrointestinal tumors:

A. Jatoi, B. R. Murphy, N. R. Foster, D. A. Nikcevich, S. R. Alberts, J. A. Knost, T. R. Fitch, and K. M. Rowland, Jr

Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
Annals of Oncology Advance Access published on November 22, 2005
Ann Oncol 17: 29-34; doi:10.1093/annonc/mdj063
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. H. Smorenburg, G. J. Peters, C. J. van Groeningen, P. Noordhuis, K. Smid, A. M. G. H. van Riel, W. Dercksen, H. M. Pinedo, and G. Giaccone

Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 35-42; doi:10.1093/annonc/mdj046
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

H. Orita, N. Sakamoto, Y. Ajioka, T. Terai, O. Hino, N. Sato, T. Shimoda, T. Kamano, M. Tsurumaru, and H. Fujii

Allelic loss analysis of early-stage flat-type colorectal tumors
Annals of Oncology Advance Access published on October 25, 2005
Ann Oncol 17: 43-49; doi:10.1093/annonc/mdj017
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

R. Glynne-Jones, D. Sebag-Montefiore, T. S. Maughan, S. J. Falk, and A. C. McDonald

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
Annals of Oncology Advance Access published on November 10, 2005
Ann Oncol 17: 50-56; doi:10.1093/annonc/mdj031
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

breast cancer:

J-L. Bulliard, C. La Vecchia, and F. Levi

Diverging trends in breast cancer mortality within Switzerland
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 57-59; doi:10.1093/annonc/mdj035
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

I. Conde, R. Paniagua, J. Zamora, M. J. Blánquez, B. Fraile, A. Ruiz, and M. I. Arenas

Influence of thyroid hormone receptors on breast cancer cell proliferation
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 60-64; doi:10.1093/annonc/mdj040
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Namer, P. Fargeot, H. Roché, M. Campone, P. Kerbrat, P. Romestaing, A. Monnier, E. Luporsi, P. Montcuquet, and J. Bonneterre On behalf of the FASG (French Adjuvant Study Group)

Improved disease-free survival with epirubicin-based chemoendocrine adjuvant therapy compared with tamoxifen alone in one to three node-positive, estrogen-receptor-positive, postmenopausal breast cancer patients: results of French Adjuvant Study Group 02 and 07 trials
Ann Oncol 17: 65-73; doi:10.1093/annonc/mdj022
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

L. Del Mastro, T. Catzeddu, L. Boni, C. Bell, M. R. Sertoli, C. Bighin, M. Clavarezza, D. Testa, and M. Venturini

Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients
Annals of Oncology Advance Access published on October 27, 2005
Ann Oncol 17: 74-78; doi:10.1093/annonc/mdj029
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Di Costanzo, S. Gasperoni, P. Papaldo, D. Bilancia, L. Manzione, E. Landucci, F. Mazzoni, and F. Cognetti On behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) and Gruppo Oncologico del Lazio (GOL)

Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL
Annals of Oncology Advance Access published on November 10, 2005
Ann Oncol 17: 79-84; doi:10.1093/annonc/mdj033
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Fumoleau, H. Roché, P. Kerbrat, J. Bonneterre, P. Romestaing, P. Fargeot, M. Namer, A. Monnier, P. Montcuquet, M.-J. Goudier, and E. Luporsi On behalf of the French Adjuvant Study Group

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 85-92; doi:10.1093/annonc/mdj034
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

gynecologic tumors:

A. du Bois, A. Burges, W. Meier, J. Pfisterer, B. Schmalfeldt, B. Richter, C. Jackisch, A. Staehle, R. Kimmig, and G. Elser On behalf of AGO-OVAR Germany

Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 93-96; doi:10.1093/annonc/mdj032
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

lung cancer:

A. Kurup, C.-W. Lin, D. J. Murry, L. Dobrolecki, D. Estes, C. T. Yiannoutsos, L. Mariano, C. Sidor, R. Hickey, and N. Hanna

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University
Annals of Oncology Advance Access published on November 9, 2005
Ann Oncol 17: 97-103; doi:10.1093/annonc/mdj055
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. A. Socinski, A. Ivanova, K. Bakri, J. Wall, M. Q. Baggstrom, T. A. Hensing, A. Mears, M. Tynan, J. Beaumont, A. H. Peterman, and H. B. Niell

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
Annals of Oncology Advance Access published on October 25, 2005
Ann Oncol 17: 104-109; doi:10.1093/annonc/mdj016
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

hematologic malignancies:

K. Karube, K. Ohshima, J. Suzumiya, R. Kawano, M. Kikuchi, and M. Harada

Gene expression profile of cytokines and chemokines in microdissected primary Hodgkin and Reed–Sternberg (HRS) cells: high expression of interleukin-11 receptor
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 110-116; doi:10.1093/annonc/mdj064
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

P. Raanani, Y. Shasha, C. Perry, U. Metser, E. Naparstek, S. Apter, A. Nagler, A. Polliack, I. Ben-Bassat, and E. Even-Sapir

Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era?
Annals of Oncology Advance Access published on September 28, 2005
Ann Oncol 17: 117-122; doi:10.1093/annonc/mdj024
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

K. J. Savage, N. Al-Rajhi, N. Voss, C. Paltiel, R. Klasa, R. D. Gascoyne, and J. M. Connors

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience
Annals of Oncology Advance Access published on October 19, 2005
Ann Oncol 17: 123-130; doi:10.1093/annonc/mdj030
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

A. Ghavamzadeh, K. Alimoghaddam, S. H. Ghaffari, S. Rostami, M. Jahani, R. Hosseini, A. Mossavi, E. Baybordi, A. Khodabadeh, M. Iravani, B. Bahar, Y. Mortazavi, M. Totonchi, and N. Aghdami

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
Annals of Oncology Advance Access published on October 14, 2005
Ann Oncol 17: 131-134; doi:10.1093/annonc/mdj019
[Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]

K. Tanimoto, A. Kaneko, S. Suzuki, N. Sekiguchi, D. Maruyama, S. W. Kim, T. Watanabe, Y. Kobayashi, Y. Kagami, A. Maeshima, Y. Matsuno, and K. Tobinai

Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma
Annals of Oncology Advance Access published on October 19, 2005
Ann Oncol 17: 135-140; doi:10.1093/annonc/mdj025
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. de Jong, J. Bosq, K. A. MacLennan, J. Diebold, J. Audouin, J. Chasle, A.-M. Mandard, J. Marnay, and M. Henry-Amar On behalf of the European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d'Étude des Lymphomes de l'Adulte (GELA)

Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity
Annals of Oncology Advance Access published on November 10, 2005
Ann Oncol 17: 141-145; doi:10.1093/annonc/mdj037
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

quality of life and supportive care:

A. Mancuso, M. Migliorino, S. De Santis, A. Saponiero, and F. De Marinis

Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy
Annals of Oncology Advance Access published on October 26, 2005
Ann Oncol 17: 146-150; doi:10.1093/annonc/mdj038
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. A. Sandoval, C. Levinton, P. Blackstien-Hirsch, and A. D. Brown

Selecting predictors of cancer patients' overall perceptions of the quality of care received
Annals of Oncology Advance Access published on October 19, 2005
Ann Oncol 17: 151-156; doi:10.1093/annonc/mdj020
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

epidemiology:

G. D. Batty, M. J. Shipley, C. Langenberg, M. G. Marmot, and G. Davey Smith

Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study
Annals of Oncology Advance Access published on October 25, 2005
Ann Oncol 17: 157-166; doi:10.1093/annonc/mdj018
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

pediatric malignancies:

S. Viscomi, G. Pastore, E. Dama, L. Zuccolo, N. Pearce, F. Merletti, and C. Magnani

Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia
Annals of Oncology Advance Access published on October 25, 2005
Ann Oncol 17: 167-171; doi:10.1093/annonc/mdj050
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

letters to the editor:

D. Cardinale, M. Civelli, and C. M. Cipolla

Troponins in prediction of cardiotoxic effects
Annals of Oncology Advance Access published on August 12, 2005
Ann Oncol 17: 173; doi:10.1093/annonc/mdj003
[Extract] [FREE Full Text] [PDF] [Request Permissions]

S. Kilickap, I. Barista, and K. Aytemir

Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al.
Annals of Oncology Advance Access published on August 12, 2005
Ann Oncol 17: 173-174; doi:10.1093/annonc/mdj004
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Magagnoli, G. Masci, L. Castagna, E. Morenghi, and A. Santoro

High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens
Annals of Oncology Advance Access published on August 12, 2005
Ann Oncol 17: 174-176; doi:10.1093/annonc/mdj002
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. Giunta

Warfarin–5-FU interactions
Annals of Oncology Advance Access published on August 26, 2005
Ann Oncol 17: 176; doi:10.1093/annonc/mdj001
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. A. Dawson, J. Mariani, A. Taylor, G. Koulouris, and S. Avery

The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP
Annals of Oncology Advance Access published on September 12, 2005
Ann Oncol 17: 176-177; doi:10.1093/annonc/mdj005
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Tassinari, B. Poggi, E. Tamburini, M. Fantini, S. Nicoletti, and S. Sartori

Quality of care in clinical oncology: from the dreamworld to the real world of outcome assessment
Annals of Oncology Advance Access published on August 19, 2005
Ann Oncol 17: 177-178; doi:10.1093/annonc/mdj006
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. R. Choudhary, P. Mishra, R. Kumar, M. Mahapatra, and V. P. Choudhry

Pregnancy on imatinib: fatal outcome with meningocele
Annals of Oncology Advance Access published on November 15, 2005
Ann Oncol 17: 178-179; doi:10.1093/annonc/mdj065
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.